Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Elm And Carlton St
Buffalo, NY 14263Phone+1 716-845-2300Fax+1 716-845-2993- Is this information wrong?
Education & Training
- University of Michigan Health SystemFellowship, Hematology and Medical Oncology, 1987 - 1990
- University of ColoradoResidency, Internal Medicine, 1984 - 1987
- University of Michigan Medical SchoolClass of 1984
Certifications & Licensure
- IN State Medical License 2021 - 2025
- NY State Medical License 2007 - 2024
- FL State Medical License 1999 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma Start of enrollment: 2000 Jun 01
- Fludarabine and Thalidomide in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia Start of enrollment: 2002 May 01
- Lenalidomide With or Without Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia Start of enrollment: 2004 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsCD8+ T cell metabolic flexibility elicited by CD28-ARS2 axis-driven alternative splicing of PKM supports antitumor immunity.Holling, G., Chavel, C., Sharda, A., Lieberman, M., James, C., Lightman, S., Tong, J., Qiao, G., Emmons, T., Giridharan, T., Hou, S., Intlekofer, A., Higashi, R., Fan,...> ;Cellular & Molecular Immunology. 2024 Mar 1
- A Bacterial and Ganglioside-based Nanoparticle Initiates Reprogramming of Macrophages and Promotes Antitumor Phenotypes.Alvarez-Arzola, R., Oliver, L., Messmer, M., Twum, D., Muhitch, J., Mesa, C., Abrams, S., Lee, K.> ;Journal of Immunology. 2024 Feb 1
- Identifying novel mechanisms of biallelic TP53 loss refines poor outcome for patients with multiple myeloma.Enze Liu, Parvathi Sudha, Nathan Becker, Oumaima Jaouadi, Attaya Suvannasankha, Kelvin Lee, Rafat Abonour, Mohammad Abu Zaid, Brian A Walker> ;Blood Cancer Journal. 2023 Sep 11
- Join now to see all
Press Mentions
- IU School of Medicine Names First Walther Scholar in Psycho-OncologyApril 26th, 2022
- Students Present Their Summer Research ProjectsSeptember 13th, 2021
- New IU Simon Comprehensive Cancer Center Director Lays Out His VisionApril 29th, 2021
- Join now to see all
Grant Support
- Multidisciplinary Approaches To Tumor ImmunologyNational Cancer Institute2007–2011
- Cd28-Mediated Regulation Of Multiple Myeloma Cell Proliferation And SurvivalNational Cancer Institute2007–2011
- Extramural Research Facility Construction Projects. Ros*National Center For Research Resources2010
- Program LeadersNational Cancer Institute2008
- Human Hematopoietic And Immune Cell BankNational Cancer Institute2006
- Arsenic Trioxide &Ascorbic Acid For Multiple MyelomaNational Cancer Institute2006
- Arsenic Trioxide &Ascorbic Acid For Multiple MyelomaNational Cancer Institute2002–2006
- Human Hematopoietic And Immune Cell BankNational Cancer Institute2002–2005
- Induced Leukemic Cell Differentiation To Dendritc CellNational Cancer Institute1999–2003
Hospital Affiliations
- Indiana University Health North HospitalCarmel, Indiana
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: